RMD Shares ResMed Inc.

STRONG BUY ASX · ASX

$35.50 -0.95% Prices as of close 2026-10-26

Strong broker support, durable sleep-apnoea demand, and positive earnings expectations create attractive forward value.

Future value: $39.75 (+11.99%) · 6-12 months · analyst consensus

Signal breakdown

▸Majority broker buy ratings and 18% average target upside
▸Above 50-day MA (+9.73%)
▸Above 200-day MA — long-term uptrend
▸Volume 1.54× average — accumulation

Is RMD a buy right now?

Trend: RMD is trading above the 50-day average (+10.45%), RSI 32 — neutral momentum, with a 3-month return of +18.48%.

Valuation & quality: ResMed Inc. trades on a trailing P/E of 23.3, forward P/E 18.9, PEG 1.35, price-to-book 2.21; fundamentals show net margin 26.9%, return on equity 24.3%, revenue growth 8.6% year on year.

Analyst consensus: 13 analysts have a mean 12-month price target of A$40.19 (+13.2% vs the last close; range A$33.52 – A$47.57), consensus rating “buy”.

Income: trailing dividend yield 1.05%.

Our screen: STRONG BUY (score 5) — Strong broker support, durable sleep-apnoea demand, and positive earnings expectations create attractive forward value.

Computed from end-of-day data; not personal advice.

Our track record with RMD

Our simulated $10,000 funds have traded RMD 1 time, 1 position still open.

Fund	Bought	Sold	Return
ASX Medium-risk	2026-10-12 @ $34.26	Still held · $35.84	+4.61%

Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.

12-month price chart

Daily close, 2026-02-08 → 2026-10-26 (AUD). Range 25.8 – 38.6.

Monthly returns

Mar 26	Apr 26	May 26	Jun 26	Jul 26	Aug 26	Sep 26	Oct 26
-9.30%	-9.00%	-3.50%	+0.50%	+3.20%	+10.90%	-3.20%	+12.10%

Fundamentals

Market cap

$50.41B

P/E (ttm)

23.3

Forward P/E

18.9

EPS (ttm)

$1.54

Price / book

2.21

PEG

1.35

Beta

0.75

Net margin

26.9%

ROE

24.3%

Revenue growth

8.6%

Earnings growth

2.4%

Revenue (ttm)

$5.65B

Free cash flow

$939.2M

Debt / equity

13%

Dividend yield

1.05%

52-wk range

$25.50 – $40.19

Volume

1,772,498

Avg volume (3m)

1,501,091

Analyst price target

Mean target

$40.19

Low

$33.52

High

$47.57

Analysts

Consensus

BUY

Technical signals

RSI (14)

31.6

vs 50-day MA

+10.45%

1-mo return

+13.27%

3-mo return

+18.48%

Volume z-score

1.29

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.

Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 11,370 employees · Website

Related Health Care picks

CSL.AXCSL Limited PME.AXPro Medicus Limited COH.AXCochlear Limited FPH.AXFisher & Paykel Health RHC.AXRamsay Health Care Lim NAN.AXNanosonics Limited SIG.AXSigma Healthcare Limit EBO.AXEBOS Group Limited

Browse: all ASX stocks · Health Care picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.